Luis Fayad
The University of Texas MD Anderson Cancer Center(US)The University of Texas MD Anderson Cancer Center(US)Holy Spirit University of Kaslik(LB)Esprit (Slovakia)(SK)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Viral-associated cancers and disorders, CAR-T cell therapy research, CNS Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas(2020)570 cited
- → High Rate of Durable Remissions After Treatment of Newly Diagnosed Aggressive Mantle-Cell Lymphoma With Rituximab Plus Hyper-CVAD Alternating With Rituximab Plus High-Dose Methotrexate and Cytarabine(2005)558 cited
- → Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial(2013)529 cited
- → Phase II Study of Proteasome Inhibitor Bortezomib in Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma(2004)526 cited
- → Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins(2013)495 cited
- →